Dose, Safety, Tolerability and Immunogenicity of a Stabilized Prefusion RSV F Subunit Protein Vaccine, VRC-RSVRGP084-00-VP (DS-Cav1), Alone or With Alum Adjuvant, in Healthy Adults
Clinical trial NCT03049488 · COMPLETED
Trial details
- NCT number
- NCT03049488
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-22
- Primary completion
- 2019-10-03
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.